Power Law company profile

Verastem

Biotech & Life Sciences · Needham, United States · Founded 2010 · IPO 2012 Colt

Verastem - Novel Drugs Targeting Cancer Stem Cells

Valuation

$351M

Market cap · May/2026

Revenue

$31M

Latest reported FY

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

12 investors on Verastem's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Cardinal Partners

Bessemer Venture Partners

MPM BioImpact

Longwood Fund

Series B+ 8 investors entered at this stage

Nantahala Capital Management

BVF Partners

Stonepine Capital Management

RTW Investments

Advanced Technology Ventures

Astellas Venture

OrbiMed

Octagon Capital Partners

Global footprint

Where Verastem has talent and traffic

Workforce by country

🇺🇸 United States · Needham HQ

Book a demo for the full country breakdown

Web traffic by country

6.7K monthly visits
across markets

🇺🇸 United States74.6%

🇮🇳 India16.4%

🇨🇦 Canada7.5%

🇪🇸 Spain1.5%

Top 4 markets shown

Market sentiment

What the market is saying about Verastem

An AI-synthesized read of the highest-engagement posts about Verastem on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Verastem on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles